Patient Participation

Abstract

Patient participation is the involvement of patients in decisions about their own health care, the broad behavior of which shared decision making is the most studied form. It spans a spectrum from being merely informed to jointly owning the choice, and it rests on a specific cognitive premise: for preference-sensitive decisions, where reasonable options differ mainly in how their benefits and harms are valued, no clinically correct answer exists until the patient's own weighting of outcomes is supplied. This article defines participation and distinguishes it from consent and compliance, locates it on a ladder of involvement, formalizes the preference-weighting logic that makes two patients rationally prefer opposite treatments from identical evidence, and treats patient activation as a measurable trait. Three interactive demonstrations and a worked example make the mechanism concrete.

Keywords: patient participation, shared decision making, patient activation

Medicine spent most of its history treating the patient as the object of a decision rather than a party to it. The clinician held the knowledge, judged what was best, and the patient's role was to accept or refuse. Patient participation names the reversal of that default: an arrangement in which the patient is an active contributor to decisions about their own care, bringing something the clinician cannot supply from the outside, namely how this person values the outcomes at stake. The MeSH descriptor defines it as patient involvement in the decision-making process in matters pertaining to health, and files it under patient acceptance of health care, alongside treatment adherence and patient dropout.

The concept is easy to endorse and easy to misread. It does not mean the clinician withholds a recommendation, nor that every decision is handed to the patient, nor that participation is the same thing as being informed. It means that for a large class of decisions, the evidence alone is not sufficient to pick an option, and the missing input is the patient's considered preference. The sections below make that claim precise.

What Patient Participation Is

Patient participation is best defined by contrast with the arrangements it displaces. Under paternalism, the clinician decides and the patient receives the decision; the patient's only lever is refusal. Under pure consumerism, the patient decides alone and the clinician is a technician supplying information on request. Participation, and its central model shared decision making, occupies the middle: the two parties bring different and complementary expertise to a joint decision. Cathy Charles and colleagues fixed this definition in an influential pair of papers, specifying that shared decision making requires at least two participants, a two-way exchange of information, a shared deliberation, and a decision that both parties agree to and own (Charles et al., 1997; Charles et al., 1999).

The distinction that does the most work is between participation and three things it is routinely confused with. Informed consent is a legal and ethical threshold: the patient must understand and authorize what is done to them. It is necessary but minimal, a one-time gate rather than a shared process. Compliance, or adherence, is the patient executing a plan the clinician set; participation concerns who sets the plan. And being informed is an input to participation, not participation itself. A patient handed a stack of pamphlets has been informed; a patient whose values shaped which option was chosen has participated. Barry and Edgman-Levitan called shared decision making the pinnacle of patient-centered care precisely because it integrates these elements rather than stopping at any one of them (Barry & Edgman-Levitan, 2012).

A Ladder of Participation

Participation admits of degrees, and the most durable way to think about those degrees is as a ladder. Sherry Arnstein introduced the metaphor for citizen participation in government, arranging involvement on rungs from tokenism to genuine shared control, and warning that the lower rungs can simulate participation without conferring any real power (Arnstein, 1969). The clinical analogue runs from the clinician merely informing the patient of a decision already made, through consulting the patient for input that may or may not be used, to genuinely sharing the decision, up to the patient leading it with the clinician as adviser.

The ladder makes a point that a binary yes-or-no view of participation misses: many arrangements that call themselves participatory sit on the lower rungs. Soliciting a patient's view after the plan is fixed, or offering a choice among options the clinician has already filtered, is consultation dressed as partnership. The demonstration below moves a decision up and down the rungs and shows how the locus of control shifts between clinician and patient at each level.

Select a rung. The bar shows where control sits between clinician and patient; higher rungs move control toward the patient.

Shared. Clinician and patient exchange evidence and values, deliberate, and jointly own the decision. The pivot of the ladder.

The right rung is not always the top one. An emergency, a decision with a single evidence-based answer, or a patient who explicitly prefers to delegate all call for less patient control, not more. The error the ladder guards against is not sitting on a low rung when that is appropriate; it is sitting on a low rung while claiming the top, so that the appearance of participation substitutes for the substance.

Shared Decision Making and the Logic of Preferences

Why should the patient's preference enter a clinical decision at all? For many decisions it should not: if one option dominates another on every outcome, the evidence settles the matter and participation adds nothing but comprehension. The decisions where participation is indispensable are preference-sensitive: cases in which the reasonable options trade off against each other, so that one is better on some outcomes and worse on others, and which one is best depends on how those outcomes are weighted. Elwyn and colleagues built this into a working clinical model, in which the clinician and patient deliberate options together rather than the clinician announcing one (Elwyn et al., 2012).

The formal structure is a weighted sum. Suppose two treatments are each scored on two attributes, say effectiveness and freedom from burden, each on a 0-to-100 scale. A patient's overall valuation of an option is the sum of its attribute scores weighted by how much that patient cares about each attribute, with the weights summing to one. The option with the higher weighted score is the one that patient should prefer. Because the weights are the patient's and not the clinician's, two patients facing identical evidence can rationally reach opposite decisions. This is not a failure of the evidence or of either patient's reasoning; it is the correct output of a decision that genuinely depends on values. The demonstration below varies the weights and shows the recommended option flip.

Treatment A is more effective (90) but more burdensome (freedom-from-burden 40). Treatment B is milder (effectiveness 60) but far easier to live with (85). Slide how much the patient weights effectiveness; the better option is the one with the higher weighted score.

Recommended for this patient: Treatment B. Nothing about the treatments changed — only the patient’s weighting. That weighting is the input only the patient can supply.

This logic is what refutes the most common objection to participation, that it abandons the patient to choices they are not equipped to make. It does the opposite. The clinician remains fully responsible for the evidence, the options, and the probabilities; what the patient supplies is only the one input that is theirs by definition. Légaré and Thompson-Leduc catalogued the myths clinicians use to avoid this, among them that patients do not want to participate and that there is no time, and showed each to be largely unfounded (Légaré & Thompson-Leduc, 2014).

Patient Activation as a Measurable Trait

Participation describes an arrangement between patient and clinician. Activation describes a property of the patient that governs how much they can take up that arrangement: the knowledge, skill, and confidence a person has to manage their own health and care. Judith Hibbard and colleagues made this trait measurable with the Patient Activation Measure, a scale that places people on a developmental continuum from passively receiving care, through acquiring knowledge and building confidence, to taking action and finally maintaining behavior under stress (Hibbard et al., 2004).

Treating activation as a measurable, movable trait rather than a fixed personality has a practical payoff. Activation predicts outcomes: more activated patients have better health outcomes and care experiences, and interventions that raise activation can improve those outcomes, which reframes participation as something a health system can cultivate rather than merely hope for (Hibbard & Greene, 2013). The demonstration below shows the four activation levels and how a given support strategy lands differently depending on where a patient currently sits.

The Patient Activation Measure places patients on four levels. Select one and see how a standard decision aid — pitched for an already-engaged patient — fits a patient at that level.

Activation is movable: matching the support to the patient’s current level, rather than delivering the same participatory script to everyone, is what the measure is for.

Activation also explains why simply exhorting patients to participate fails. A patient at the lowest level, who does not yet see themselves as having an active role, will not be moved by a decision aid designed for someone two levels up. Matching the support to the patient's current level, rather than delivering the same participatory script to everyone, is what the measure is for.

Worked Example: Two Patients, One Set of Facts

Consider a single preference-sensitive decision: two treatments, A and B, for the same condition. Treatment A is more effective but more burdensome; Treatment B is less effective but far easier to live with. The clinical facts are fixed and identical for both patients. Each option is scored on two attributes on a 0-to-100 scale, where a higher burden score means less burden:

- Treatment A: effectiveness 90, freedom-from-burden 40. - Treatment B: effectiveness 60, freedom-from-burden 85.

Each patient's valuation of an option is `w_eff x effectiveness + w_burden x freedom-from-burden`, with the two weights summing to 1. Patient 1 is a long-distance runner who prizes efficacy and will tolerate side effects, weighting effectiveness 0.75 and burden 0.25. Patient 2 is frail and prizes quality of daily life, weighting effectiveness 0.25 and burden 0.75.

Patient 1's figures are `0.75 x 90 + 0.25 x 40 = 77.5` for A against `0.75 x 60 + 0.25 x 85 = 66.25` for B, so A wins. Patient 2's are `0.25 x 90 + 0.75 x 40 = 52.5` for A against `0.25 x 60 + 0.75 x 85 = 78.75` for B, so B wins. Same evidence, same options, same scores on the attributes; opposite correct answers. A paternalistic system would pick one treatment for both patients and be wrong for one of them. The point of participation is not politeness; it is that the system cannot identify the better option without the weights, and only the patient holds them.

Discussion

The case for patient participation is often made in the language of ethics and autonomy, and that case is real. But the argument this article has pressed is epistemic, and it is stronger for being so: for preference-sensitive decisions, the information needed to choose well is distributed across two parties, and no amount of clinical expertise can supply the half that lives in the patient. Participation is the procedure for assembling the whole. This reframes the clinician's job not as deciding for the patient nor as abdicating to them, but as the harder task of eliciting values accurately and integrating them with evidence.

The evidence that this can be operationalized is substantial. Syntheses of strategies for informing, educating, and involving patients find that structured approaches outperform the ad hoc encouragement that passes for participation in most settings (Coulter & Ellins, 2007). The caution is that participation is easy to counterfeit. The ladder's lower rungs, decisions presented as choices after the real filtering has happened, or consultation whose input changes nothing, let a system claim participation while withholding it. Measuring activation and auditing whether patients' values actually moved decisions are the checks against that counterfeit.

Cognitive Implications

Patient participation is a cognitive phenomenon before it is a policy. The elicitation of preferences runs straight into the findings of judgment and decision-making research: preferences are often constructed in the moment rather than retrieved intact, and they are sensitive to how options are framed, to the order in which attributes are presented, and to the reference point against which outcomes are judged (Slovic, 1995). A patient told an option has a 90% survival rate participates differently from one told it has a 10% mortality rate, though the facts are identical. This makes the manner of participation consequential: a decision aid that frames outcomes one way will tilt the constructed preference, so neutral presentation is not a nicety but a condition of valid elicitation.

Communication is the causal channel. Street and colleagues mapped the pathways by which clinician-patient communication reaches health outcomes, direct effects on understanding and emotion, and indirect effects through trust, adherence, and the quality of the decision itself, showing that participation works partly because better communication is itself therapeutic (Street et al., 2009). The implication is that participation cannot be bolted on as a form to sign; it is realized or lost in the texture of the conversation, which is why the cognitive quality of that conversation, not merely its occurrence, is what determines whether participation is genuine.

Current Directions

The most consolidated recent evidence concerns decision aids, the tools, from leaflets to interactive programs, designed to present options and help patients deliberate. The Cochrane review of over a hundred randomized trials found that decision aids improve patients' knowledge, give them more accurate risk perceptions, and leave them clearer about what matters to them, with no evidence of harm (Stacey et al., 2017). This moves participation from exhortation to intervention: there is now a tested technology for supporting it.

A parallel strand works on making shared decision making doable in a short consultation. Elwyn and colleagues distilled their model into a three-talk structure, team talk, option talk, and decision talk, intended to fit the realities of clinical time while preserving the two-way logic (Elwyn et al., 2017). Beyond the individual encounter, participation is expanding to the design of care itself: a systematic review of engaging patients in quality improvement found that involving patients in how services are run, not only in their own treatment, is being tried across health systems, though the evidence on its effects is still maturing (Bombard et al., 2018). The open questions are no longer whether patients can participate but how to embed it reliably, how to reach patients at low activation, and how to tell genuine participation from its forms.

Common Misconceptions

Participation means the clinician stops giving recommendations.

No. In the working model, the clinician remains the authority on evidence, options, and probabilities and may recommend; what changes is that the patient's values enter the choice rather than being presumed. Withholding a recommendation is abandonment, not participation (Elwyn et al., 2012).

If a patient gives informed consent, they have participated.

Consent is a one-time authorization threshold, minimal and often reached after the real decision is made. Participation is shared authorship of that decision, which Barry and Edgman-Levitan call the pinnacle of patient-centered care; a consented patient may have participated in nothing (Barry & Edgman-Levitan, 2012).

Participation is appropriate for every decision.

No. Emergencies, decisions with a single dominant option, and patients who prefer to delegate all call for less patient control; the claim that patients always or never want to participate is itself one of the catalogued myths. Participation is indispensable specifically for preference-sensitive decisions (Légaré & Thompson-Leduc, 2014).

Two patients choosing opposite treatments from the same facts means one is wrong.

Not for a preference-sensitive decision. When options trade off, the better one depends on how outcomes are weighted, and the weights differ legitimately between patients, so deliberating the options together rather than announcing one is the point. Opposite choices can both be correct (Elwyn et al., 2012).

Glossary

Autonomy.

The patient's right to self-determination in decisions about their own body and care; the ethical principle that participation operationalizes.

Decision aid.

A tool, from a leaflet to an interactive program, that presents options and outcomes and helps a patient clarify and apply their own values to a choice.

Health literacy.

The capacity to obtain, process, and understand health information well enough to make decisions; a precondition for meaningful participation.

Informed consent.

The ethical and legal requirement that a patient understand and authorize an intervention; a necessary threshold but a one-time gate rather than shared deliberation.

Ladder of participation.

Arnstein's metaphor arranging involvement on rungs from tokenism to genuine shared control, warning that lower rungs can simulate participation without conferring power.

Paternalism.

The arrangement in which the clinician decides on the patient's behalf and the patient's role is limited to accepting or refusing.

Patient Activation Measure (PAM).

A validated scale placing patients on a developmental continuum of activation, from passive recipient to confident self-manager.

Patient activation.

The knowledge, skill, and confidence a person has to manage their own health and care, treated as a measurable and movable trait.

Patient participation.

The involvement of patients in decisions about their own health care, spanning being informed, consulted, and jointly deciding.

Patient-centered care.

Care organized around the individual patient's values, preferences, and needs, of which shared decision making is considered the defining act.

Preference-sensitive decision.

A decision in which reasonable options trade off against one another, so that the best choice depends on how the patient weights the competing outcomes.

Self-management.

The patient's ongoing role in monitoring and managing a chronic condition, the behavioral extension of participation beyond the single decision.

Shared decision making.

The model in which clinician and patient exchange information, deliberate options together, and jointly own the resulting decision; the central form of participation.

Three-talk model.

Elwyn and colleagues' structure for shared decision making in practice: team talk, option talk, and decision talk.

Key Researchers

Cathy Charles

(McMaster University, d. 2015). Health policy scholar whose 1997 and 1999 papers with Amiram Gafni and Tim Whelan gave shared decision making its still-standard definition, requiring at least two participants, two-way information exchange, shared deliberation, and a jointly owned decision. Her analysis separated shared decision making from both paternalism and the purely informed model. McMaster CHEPA

Angela Coulter

(University of Oxford). Health policy researcher whose syntheses of the evidence on informing, educating, and involving patients established which strategies actually raise participation, and whose work on patient-centred care shaped national policy on patient engagement. Faculty page · Google Scholar

Glyn Elwyn

(Dartmouth Institute for Health Policy and Clinical Practice). Physician-researcher who turned shared decision making into something clinicians can do and researchers can score, through the three-talk model and the Option Grid and CollaboRATE measures. ORCID · Faculty page · Google Scholar · Wikipedia

Judith H. Hibbard

(University of Oregon). Health policy researcher who developed the Patient Activation Measure, reframing participation as a measurable developmental trait and showing that higher activation predicts better outcomes and care experiences. ORCID · Faculty page · Google Scholar · Wikipedia

France Légaré

(Université Laval). Family physician and implementation scientist who led the Cochrane review of decision aids and the trials of how to embed shared decision making in routine practice, and who catalogued the myths clinicians use to avoid it. ORCID · Faculty page · Google Scholar · Wikipedia

Frequently Asked Questions

What is patient participation?

Patient participation is the involvement of patients in decisions about their own health care. It spans a spectrum from being informed of a decision, through being consulted, to jointly owning the choice with the clinician, and its central case is the preference-sensitive decision, where the patient's values are needed to pick the best option (Charles et al., 1997).

How is participation different from informed consent?

Informed consent is a one-time threshold: the patient must understand and authorize what is done to them. Participation is the ongoing shared authorship of the decision itself. A patient can give valid consent to a plan they had no hand in choosing, so consent is necessary but far short of participation (Barry & Edgman-Levitan, 2012).

What is shared decision making?

Shared decision making is the operational model of participation: the clinician contributes evidence about the options and their outcomes, the patient contributes their values and goals, and the two deliberate and reach a decision they both own. It requires at least two active participants and a genuine two-way exchange (Charles et al., 1999; Elwyn et al., 2012).

Why should a patient's preferences change a medical decision?

Because many decisions are preference-sensitive: the reasonable options trade off, so which is best depends on how the outcomes are weighted. The clinician cannot supply that weighting from outside, so two patients can correctly choose opposite treatments from identical evidence (Elwyn et al., 2012).

What is patient activation, and can it be measured?

Patient activation is the knowledge, skill, and confidence a person has to manage their own health. The Patient Activation Measure scores it on a developmental continuum, and higher activation predicts better health outcomes and care experiences, which makes it something a health system can cultivate (Hibbard et al., 2004; Hibbard & Greene, 2013).

Do decision aids actually help?

Yes. A Cochrane review of over a hundred randomized trials found that decision aids improve patients' knowledge, give them more accurate perceptions of risk, and leave them clearer about what matters to them, with no evidence of harm (Stacey et al., 2017).

Is patient participation always appropriate?

No. Emergencies, decisions with a single dominant option, and patients who explicitly prefer to delegate all call for less patient control. Participation is indispensable specifically where options are preference-sensitive, and even then the right degree of involvement varies (Légaré & Thompson-Leduc, 2014).

Does participation improve health outcomes or just satisfaction?

Both are implicated. Better clinician-patient communication, the channel through which participation works, has direct effects on understanding and emotion and indirect effects through trust and adherence, so participation can reach outcomes and not only the experience of care (Street et al., 2009; Coulter & Ellins, 2007).

References